CHARLES RIVER LABORATORIES INTERNATIONAL, INC. Amortization of Debt Issuance Costs and Discounts
CHARLES RIVER LABORATORIES INTERNATIONAL, INC. (CRL) reported Amortization of Debt Issuance Costs and Discounts of $2.83 million for the 12-month period ending 2016-12-31, per its 10-K filed 2017-02-14.
Discontinued › Cash Flow › Operating Activities
us-gaap:AmortizationOfFinancingCostsAndDiscounts · last filed 2017-02-14
- CHARLES RIVER LABORATORIES INTERNATIONAL, INC. amortization of debt issuance costs and discounts for the quarter ending 2016-12-31 was $506.00K, a 23.41% increase year-over-year.
- CHARLES RIVER LABORATORIES INTERNATIONAL, INC. amortization of debt issuance costs and discounts for the quarter ending 2016-09-24 was $34.00K, a 91.46% decline year-over-year.
- CHARLES RIVER LABORATORIES INTERNATIONAL, INC. amortization of debt issuance costs and discounts for the quarter ending 2016-06-25 was $1.88M, a 63.79% increase year-over-year.
- CHARLES RIVER LABORATORIES INTERNATIONAL, INC. amortization of debt issuance costs and discounts for the quarter ending 2016-03-26 was $409.00K, a 3.31% decline year-over-year.
- CHARLES RIVER LABORATORIES INTERNATIONAL, INC. amortization of debt issuance costs and discounts for fiscal 2016 was $2.83M, a 18.95% increase from fiscal 2015.
- CHARLES RIVER LABORATORIES INTERNATIONAL, INC. amortization of debt issuance costs and discounts for fiscal 2015 was $2.38M, a 37.97% increase from fiscal 2014.
- CHARLES RIVER LABORATORIES INTERNATIONAL, INC. amortization of debt issuance costs and discounts for fiscal 2014 was $1.73M, a 81.96% decline from fiscal 2013.
- CHARLES RIVER LABORATORIES INTERNATIONAL, INC. amortization of debt issuance costs and discounts for fiscal 2013 was $9.56M, a 45.74% decline from fiscal 2012.
| Period end | Amortization of Debt Issuance Costs and Discounts 3 month | Amortization of Debt Issuance Costs and Discounts 6 month | Amortization of Debt Issuance Costs and Discounts 9 month | Amortization of Debt Issuance Costs and Discounts 12 month |
|---|---|---|---|---|
| 2016-12-31 | $506.00K derived: 10-K 12 month − 10-Q 9 month · filed 2017-02-14 | $540.00K derived: sum of 2 quarters · filed 2017-02-14 | $2.42M derived: sum of 3 quarters · filed 2017-02-14 | $2.83M 10-K · filed 2017-02-14 |
| 2016-09-24 | $34.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2016-11-02 | $1.92M derived: sum of 2 quarters · filed 2016-11-02 | $2.33M 10-Q · filed 2016-11-02 | $2.73M derived: sum of 4 quarters · filed 2017-02-14 |
| 2016-06-25 | $1.88M derived: 10-Q 6 month − 10-Q 3 month · filed 2016-08-03 | $2.29M 10-Q · filed 2016-08-03 | $2.70M derived: sum of 3 quarters · filed 2017-02-14 | $3.10M derived: sum of 4 quarters · filed 2017-02-14 |
| 2016-03-26 | $409.00K 10-Q · filed 2016-05-04 | $819.00K derived: sum of 2 quarters · filed 2017-02-14 | $1.22M derived: sum of 3 quarters · filed 2017-02-14 | $2.37M derived: sum of 4 quarters · filed 2017-02-14 |
| 2015-12-26 | $410.00K derived: 10-K 12 month − 10-Q 9 month · filed 2017-02-14 | $808.00K derived: sum of 2 quarters · filed 2017-02-14 | $1.96M derived: sum of 3 quarters · filed 2017-02-14 | $2.38M 10-K · filed 2017-02-14 |
| 2015-09-26 | $398.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2016-11-02 | $1.55M derived: sum of 2 quarters · filed 2016-11-02 | $1.97M 10-Q · filed 2016-11-02 | $2.40M derived: sum of 4 quarters · filed 2017-02-14 |
| 2015-06-27 | $1.15M derived: 10-Q 6 month − 10-Q 3 month · filed 2016-08-03 | $1.57M 10-Q · filed 2016-08-03 | $2.00M derived: sum of 3 quarters · filed 2017-02-14 | $2.43M derived: sum of 4 quarters · filed 2017-02-14 |
| 2015-03-28 | $423.00K 10-Q · filed 2016-05-04 | $850.00K derived: sum of 2 quarters · filed 2017-02-14 | $1.28M derived: sum of 3 quarters · filed 2017-02-14 | $1.71M derived: sum of 4 quarters · filed 2017-02-14 |
| 2014-12-27 | $427.00K derived: 10-K 12 month − 10-Q 9 month · filed 2017-02-14 | $857.00K derived: sum of 2 quarters · filed 2017-02-14 | $1.29M derived: sum of 3 quarters · filed 2017-02-14 | $1.73M 10-K · filed 2017-02-14 |
| 2014-09-27 | $430.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2015-11-04 | $863.00K derived: sum of 2 quarters · filed 2015-11-04 | $1.30M 10-Q · filed 2015-11-04 | $1.74M derived: sum of 4 quarters · filed 2016-02-12 |
| 2014-06-28 | $433.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2015-07-30 | $868.00K 10-Q · filed 2015-07-30 | $1.30M derived: sum of 3 quarters · filed 2016-02-12 | $1.73M derived: sum of 4 quarters · filed 2016-02-12 |
| 2014-03-29 | $435.00K 10-Q · filed 2015-04-30 | $872.00K derived: sum of 2 quarters · filed 2016-02-12 | $1.30M derived: sum of 3 quarters · filed 2016-02-12 | $5.44M derived: sum of 4 quarters · filed 2016-02-12 |
| 2013-12-28 | $437.00K derived: 10-K 12 month − 10-Q 9 month · filed 2016-02-12 | $866.00K derived: sum of 2 quarters · filed 2016-02-12 | $5.00M derived: sum of 3 quarters · filed 2016-02-12 | $9.56M 10-K · filed 2016-02-12 |
| 2013-09-28 | $429.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2014-10-30 | $4.57M derived: sum of 2 quarters · filed 2014-10-30 | $9.12M 10-Q · filed 2014-10-30 | $13.61M derived: sum of 4 quarters · filed 2015-02-17 |
| 2013-06-29 | $4.14M derived: 10-Q 6 month − 10-Q 3 month · filed 2014-08-07 | $8.70M 10-Q · filed 2014-08-07 | $13.18M derived: sum of 3 quarters · filed 2015-02-17 | $17.66M derived: sum of 4 quarters · filed 2015-02-17 |
| 2013-03-30 | $4.56M 10-Q · filed 2014-04-30 | $9.04M derived: sum of 2 quarters · filed 2015-02-17 | $13.52M derived: sum of 3 quarters · filed 2015-02-17 | $17.83M derived: sum of 4 quarters · filed 2015-02-17 |
| 2012-12-29 | $4.49M derived: 10-K 12 month − 10-Q 9 month · filed 2015-02-17 | $8.96M derived: sum of 2 quarters · filed 2015-02-17 | $13.28M derived: sum of 3 quarters · filed 2015-02-17 | $17.62M 10-K · filed 2015-02-17 |
| 2012-09-29 | $4.47M derived: 10-Q 9 month − 10-Q 6 month · filed 2013-10-30 | $8.79M derived: sum of 2 quarters · filed 2013-10-30 | $13.14M 10-Q · filed 2013-10-30 | $17.92M derived: sum of 4 quarters · filed 2014-02-25 |
| 2012-06-30 | $4.32M derived: 10-Q 6 month − 10-Q 3 month · filed 2013-07-31 | $8.66M 10-Q · filed 2013-07-31 | $13.44M derived: sum of 3 quarters · filed 2014-02-25 | $19.82M derived: sum of 4 quarters · filed 2014-02-25 |
| 2012-03-31 | $4.34M 10-Q · filed 2013-05-08 | $9.13M derived: sum of 2 quarters · filed 2014-02-25 | $15.50M derived: sum of 3 quarters · filed 2014-02-25 | $20.02M derived: sum of 4 quarters · filed 2014-02-25 |
| 2011-12-31 | $4.78M derived: 10-K 12 month − 10-Q 9 month · filed 2014-02-25 | $11.16M derived: sum of 2 quarters · filed 2014-02-25 | $15.68M derived: sum of 3 quarters · filed 2014-02-25 | $20.01M 10-K · filed 2014-02-25 |
| 2011-09-24 | $6.38M derived: 10-Q 9 month − 10-Q 6 month · filed 2012-11-01 | $10.90M derived: sum of 2 quarters · filed 2012-11-01 | $15.23M 10-Q · filed 2012-11-01 | $19.35M derived: sum of 4 quarters · filed 2013-02-27 |
| 2011-06-25 | $4.52M derived: 10-Q 6 month − 10-Q 3 month · filed 2012-08-07 | $8.85M 10-Q · filed 2012-08-07 | $12.97M derived: sum of 3 quarters · filed 2013-02-27 | $21.52M derived: sum of 4 quarters · filed 2013-02-27 |
| 2011-03-26 | $4.33M 10-Q · filed 2012-05-04 | $8.45M derived: sum of 2 quarters · filed 2013-02-27 | $17.00M derived: sum of 3 quarters · filed 2013-02-27 | |
| 2010-12-25 | $4.12M derived: 10-K 12 month − 10-Q 9 month · filed 2013-02-27 | $12.67M derived: sum of 2 quarters · filed 2013-02-27 | $19.78M 10-K · filed 2013-02-27 | |
| 2010-09-25 | $8.55M derived: 10-Q 9 month − 10-Q 6 month · filed 2011-11-02 | $15.66M 10-Q · filed 2011-11-02 | ||
| 2010-06-26 | $7.11M 10-Q · filed 2011-08-03 | |||
| 2009-12-26 | $13.80M 10-K · filed 2012-02-27 | |||
| 2008-12-27 | $13.46M 10-K · filed 2011-02-23 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Medpace Holdings, Inc. (MEDP) | United States | $17.316B | 30.09 |
| INCYTE CORP (INCY) | United States | $24.855B | 13.14 |
| Absci Corp (ABSI) | United States | $1.775B | -14.92 |
| OmniAb, Inc. (OABI) | United States | $0.698B | -8.05 |
| NRC HEALTH (NRC) | United States | $0.450B | 42.50 |
| MAXCYTE, INC. (MXCT) | United States | $0.124B | -3.68 |
| bioAffinity Technologies, Inc. (BIAF) | United States | $0.063B | |
| OneMedNet Corp (ONMD) | $0.042B | ||
| iSpecimen Inc. (ISPC) | United States | $0.003B | |
| FOXO TECHNOLOGIES INC. (FOXO) | United States | $0.000B | -277.71 |